Moderna To Seek Emergency Use Approval For COVID-19 Vaccine Candidate
Published
Moderna, Inc. (MRNA) said it will apply for an Emergency Use approval of its Covid vaccine as the latest study showed that the vaccine candidate is 94.1% effective to prevent Covid-19. The company said there have been no serious safety concerns identified.
Full Article